EVALUASI RASIONALITAS PENGGUNAAN OBAT DIABETES MELITUS TIPE II PADA PASIEN RAWAT JALAN DI PUSKESMAS PASIR SAKTI TAHUN 2019
DOI:
https://doi.org/10.37090/jfl.v9i1.334Abstrak
Abstract
Diabetes mellitus is a metabolic disease characterized by hyperglycemia, due to abnormal insulin secretion, insulin action or both. Hyperglycemia is a condition in which blood glucose levels increase or exceed normal limits. This study aims to evaluate the treatment of type II diabetes mellitus in outpatients in Puskesmas Pasir Sakti. This research is a nonexperimental research with a descriptive design taken retrospectively. The sample in this study were all outpatients with a diagnosis of type II diabetes mellitus at Puskesmas Pasir Sakti 2019. The sampling technique used was Total sampling. The sample of this study is the medical record data of patients with type II diabetes mellitus in 2019 adjusted for inclusion criteria. Characteristics based on gender of patients with type II diabetes melitus there are 23 male patients that is 29% and 57 female patients that is 71 %. Characteristics based on the age of most patients in the Elderly (46-65 years) as many as 65 patients (81%). cases of type II diabetes mellitus patients without complications were 39 patients (49%) cases of type II diabetes mellitus patients with complications of 41 patients (51%). The results of the rationality of antidiabetic use in outpatients at the Puskesmas Pasir Sakti in 2019 According to PERKENI 2015 obtained the use of drugs based on the exact parameters indicated as much as 97.5%, the right drugs as much as 98.75%, the right dosage as much as 100%, the right way of administration as much as 100%, the exact time interval of 100%, and medication adherence of 100%. Treatment of type II diabetes melitus who received rational therapy was 96,25% while irational therapy is 3,75%.
Keywords: Diabetes Mellitus, Evaluation, Medicine, Rationality.
Referensi
American Diabetes Assosiation, Standart Of Medical Care in Diabetes. USA: Diabetes Care, 2016.
H. Arnold Hongdiyanto, Paulina, Evaluasi Kerasionalan Pengobatan Diabetes Melitus Tipe 2 pada Pasien Rawat Inap Di RSUP Prof .Dr.R.D Kandau Manado. Manado: Jurnal Ilmiah Farmasi, 2014.
Kementrian Kesehatan RI, Hasil Utama Riskesdas Tentang Prevalensi Diabetes Mellitus di Indonesia. Jakarta: Kementerian Kesehatan Republik Indonesia, 2018.
Dinas Kesehatan. Profil Kesehatan Provinsi Lampung. Lampung: Dinas Kesehatan Provinsi Lampung. 2015.
Departemen Kesehatan republik Indonesia, Pharmaceutical Care Untuk penyakit Diabetes Melitus. Jakarta: Departemen Kesehatan Republik Indonesia, 2005.
A. P. dan H. Hongdiyanto, Evaluasi Kerasionalan Pengobatan Diabetes Melitus Tipe 2 pada Pasien Rawat Inap di RSUP Prof. Manado. Manado: UNSRAT, 2013.
World Health Organization, Medicines Use In Primary Care in Developing and Transitional Countries. Geneva: World Health Organization, 2009.
Irawan D. Prevalensi dan Faktor Risiko Kejadian Diabetes Melitus Tipe 2 di Daerah Urban Indonesia. 2010 (Analisa Data Sekunder Riskesdas 2007).
ADA (American Diabetes Association). Standards of Medical Care in Diabetes. Volume 37, Alexandria: 2014. p. 516.
Sri Rahayu Yulianti. Propil Pengobatan Pasien Diabetes Melitus Tipe 2 Di Instalasi Rawat Inap RSUD Undata Palu. Prodi Farmasi UNTAD: 2014
Tri Shintya Dewi. Evaluasi Rasionalitas Penggunaan Antidiabetik Pada Pasien Rawat Inap Diabetes Melitus Tipe 2 di RSUD Karang Anyar. Surakarta: 2015.
Arifin ibrahim. Evaluasi Kerasionalan Pengobatan Diabetes Mellitus Tipe 2 pada Pasien Rawat Inap di Rumah Sakit Bhakti Wira Tamtama Semarang Universitas Wahid Hasyim, Semarang. 2012.
Perkeni, Konsensus Pengelolaan dan Pencegahan Diabetes Mellitus Tipe 2 di Indonesia. jakarta: Perkumpulan Endokrinologi Indonesia, 2015.
Astri meirinawati Evaluasi Penatalaksanaan Terapi Diabetes Melitus Komlpikasi Hipertensi Rawat Inap Rumah Sakit panti Rapih Yogyakarta: 2015
Khudz Nafi'ah, I Nyoman Wijaya. Profil Kepatuhan Pasien Puskesmas Pucang Sewu Surabaya Dalam Penggunaan Antidiabetik Oral. Jurnal Farmasi Komunitas Vol. 2, No. 1. 2015
Perkeni, Konsesus Pengendalian dan Pencegahan DM tipe 2 di Indonesia. jakarta: Perkumpulan Endokrinologi Indonesia, 2011
Departemen Kesehatan RI. Pedoman Pengendalian Diabetes Melitus dan Penyakit Metabolik. Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan Departeman Kesehatan RI. Jakarta: 2010.
